Nifty

:

25722.10

Sensex

:

83938.71

-155.75 (-0.60%)
-465.75 (-0.55%)

Login

Nifty
Sensex

:
:

25722.10
83938.71

-155.75 (-0.60%)
-465.75 (-0.55%)

Brooks Laboratories Ltd.

Pharmaceuticals & Drugs

Rating :

52/99

BSE: 533543 | NSE: BROOKS

Watchlist

NSE BSE

110.93

31-Oct-2025

Open
High
Low
Previous Close

112.8
116
110
111.62

Volume
Traded Value (lacs)
52 Week High
52 Week Low

41207
4626877.69
198.86
95.55

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

327.27
N/A
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

332.09
N/A
3.25

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

0.31
1.34
9.32

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-18.80
20.84
-

PAT CAGR (%)

10 Years
5 Years
3 Years

-11.74
-12.45
-21.86

P:E (Median)

8 Years
5 Years
3 Years

-
-
-

P:BV (Average)

8 Years
5 Years
3 Years

3.76
3.76
3.88

EV:EBITDA (Average)

8 Years
5 Years
3 Years

26.99
26.99
37.47

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var%
Net Sales 25.51 17.93 42.28% 23.32 17.72 31.60% 38.45 21.75 76.78% 20.79 24.32 -14.51%
Expenses 22.39 17.65 26.86% 21.74 17.34 25.37% 36.59 20.65 77.19% 19.28 22.60 -14.69%
EBITDA 3.13 0.28 1,017.86% 1.58 0.38 315.79% 1.86 1.10 69.09% 1.51 1.72 -12.21%
EBIDTM 12.25% 1.57% 6.75% 2.14% 4.83% 5.04% 7.26% 7.06%
Other Income 0.22 0.07 214.29% 0.62 0.65 -4.62% 0.10 0.16 -37.50% 0.20 0.09 122.22%
Interest 0.30 0.16 87.50% 0.26 0.27 -3.70% 0.45 0.21 114.29% 0.32 0.19 68.42%
Depreciation 0.39 0.40 -2.50% 0.39 0.46 -15.22% 0.78 0.43 81.40% 0.43 0.44 -2.27%
PBT 2.65 -0.21 - 1.55 0.30 416.67% 0.72 0.60 20.00% 0.96 1.18 -18.64%
Tax 0.00 0.00 0 0.18 0.00 0 0.00 0.03 -100.00% 0.00 0.00 0
PAT 2.65 -0.21 - 1.37 0.30 356.67% 0.72 0.58 24.14% 0.96 1.18 -18.64%
PATM 10.39% -1.18% 5.88% 1.72% 1.88% 2.65% 4.59% 4.85%
EPS 0.90 -0.07 - 0.47 0.10 370.00% 0.25 0.20 25.00% 0.32 0.40 -20.00%

Description Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var%
Net Sales 25.51 17.93 42.28% 23.32 17.72 31.60% 38.45 21.75 76.78% 20.79 24.32 -14.51%
Expenses 22.39 17.65 26.86% 21.78 17.34 25.61% 36.59 20.65 77.19% 19.28 22.60 -14.69%
EBITDA 3.13 0.28 1,017.86% 1.54 0.38 305.26% 1.86 1.10 69.09% 1.51 1.72 -12.21%
EBIDTM 12.25% 1.57% 6.60% 2.14% 4.83% 5.04% 7.26% 7.06%
Other Income 0.22 0.07 214.29% 0.62 0.65 -4.62% 0.10 0.16 -37.50% 0.20 0.09 122.22%
Interest 0.30 0.16 87.50% 0.26 0.27 -3.70% 0.45 0.21 114.29% 0.32 0.19 68.42%
Depreciation 0.39 0.40 -2.50% 0.39 0.46 -15.22% 0.78 0.43 81.40% 0.43 0.44 -2.27%
PBT 2.65 -0.21 - 1.51 0.30 403.33% 0.72 0.60 20.00% 0.96 1.18 -18.64%
Tax 0.00 0.00 0 0.18 0.00 0 0.03 0.03 0.00% 0.00 0.00 0
PAT 2.65 -0.21 - 1.34 0.30 346.67% 0.70 0.58 20.69% 0.96 1.18 -18.64%
PATM 10.39% -1.18% 5.73% 1.72% 1.82% 2.65% 4.59% 4.85%
EPS 3.25 -0.92 - -0.50 -3.66 - -1.74 -1.48 - -1.51 -0.62 -

Annual Results

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 108.07 82.56 79.49 55.54 76.97 77.27 69.69 55.03 55.71 57.54 80.01 Net Sales Growth 32.24% 3.86% 43.12% -27.84% -0.39% 10.88% 26.64% -1.22% -3.18% -28.08% Cost Of Goods Sold 69.97 54.07 56.62 40.46 49.27 47.77 46.84 39.43 39.38 36.66 52.95 Gross Profit 38.10 28.48 22.87 15.08 27.69 29.50 22.85 15.59 16.34 20.88 27.07 GP Margin 35.26% 34.50% 28.77% 27.15% 35.98% 38.18% 32.79% 28.33% 29.33% 36.29% 33.83% Total Expenditure 100.00 81.18 76.42 61.35 75.09 76.33 73.61 63.39 64.64 52.50 68.93 Power & Fuel Cost - 1.88 1.73 1.58 1.64 2.70 2.90 2.56 3.62 1.54 2.05 % Of Sales - 2.28% 2.18% 2.84% 2.13% 3.49% 4.16% 4.65% 6.50% 2.68% 2.56% Employee Cost - 12.45 10.09 10.65 10.88 12.04 11.16 10.04 9.65 6.16 5.20 % Of Sales - 15.08% 12.69% 19.18% 14.14% 15.58% 16.01% 18.24% 17.32% 10.71% 6.50% Manufacturing Exp. - 3.87 3.04 2.54 5.38 4.85 3.95 3.59 3.88 1.69 2.12 % Of Sales - 4.69% 3.82% 4.57% 6.99% 6.28% 5.67% 6.52% 6.96% 2.94% 2.65% General & Admin Exp. - 3.04 2.74 3.11 4.48 4.18 4.73 3.99 4.46 3.24 3.03 % Of Sales - 3.68% 3.45% 5.60% 5.82% 5.41% 6.79% 7.25% 8.01% 5.63% 3.79% Selling & Distn. Exp. - 1.40 0.99 1.52 1.68 1.54 0.95 0.73 1.03 1.82 2.05 % Of Sales - 1.70% 1.25% 2.74% 2.18% 1.99% 1.36% 1.33% 1.85% 3.16% 2.56% Miscellaneous Exp. - 4.47 1.22 1.50 1.75 3.24 3.08 3.05 2.61 1.39 2.05 % Of Sales - 5.41% 1.53% 2.70% 2.27% 4.19% 4.42% 5.54% 4.68% 2.42% 1.92% EBITDA 8.08 1.38 3.07 -5.81 1.88 0.94 -3.92 -8.36 -8.93 5.04 11.08 EBITDA Margin 7.48% 1.67% 3.86% -10.46% 2.44% 1.22% -5.62% -15.19% -16.03% 8.76% 13.85% Other Income 1.14 4.48 1.11 0.12 0.95 0.96 0.41 2.88 0.24 0.12 1.56 Interest 1.33 1.03 0.84 0.77 0.67 3.25 3.35 2.96 2.40 1.01 0.79 Depreciation 1.99 1.60 1.77 1.72 1.49 7.09 6.65 6.50 6.45 1.67 1.16 PBT 5.88 3.23 1.55 -8.18 0.67 -8.44 -13.51 -14.95 -17.53 2.48 10.69 Tax 0.18 0.18 0.03 0.00 0.00 7.15 10.86 -0.14 -3.72 0.82 0.19 Tax Rate 3.06% 5.57% 1.94% 0.00% 0.00% -84.72% -80.38% 0.94% 21.22% 33.06% 1.76% PAT 5.70 3.05 1.53 -8.18 0.67 -15.59 -24.38 -14.81 -13.81 1.67 10.63 PAT before Minority Interest 5.70 3.05 1.53 -8.18 0.67 -15.59 -24.38 -14.81 -13.81 1.67 10.63 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 5.27% 3.69% 1.92% -14.73% 0.87% -20.18% -34.98% -26.91% -24.79% 2.90% 13.29% PAT Growth 208.11% 99.35% - - - - - - - -84.29% EPS 1.93 1.03 0.52 -2.77 0.23 -5.28 -8.26 -5.02 -4.68 0.57 3.60

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21
Net Sales 108.07 82.56 79.49 63.20 91.18 77.25 Net Sales Growth 32.24% 3.86% 25.78% -30.69% 18.03% Cost Of Goods Sold 69.97 54.07 56.62 50.60 62.79 47.57 Gross Profit 38.10 28.48 22.87 12.60 28.40 29.67 GP Margin 35.26% 34.50% 28.77% 19.94% 31.15% 38.41% Total Expenditure 100.04 81.22 76.42 89.62 105.44 76.73 Power & Fuel Cost - 1.88 1.73 3.23 3.99 2.70 % Of Sales - 2.28% 2.18% 5.11% 4.38% 3.50% Employee Cost - 12.45 10.09 16.00 16.85 12.04 % Of Sales - 15.08% 12.69% 25.32% 18.48% 15.59% Manufacturing Exp. - 3.87 3.04 7.85 9.53 5.44 % Of Sales - 4.69% 3.82% 12.42% 10.45% 7.04% General & Admin Exp. - 3.04 2.74 5.42 6.37 4.19 % Of Sales - 3.68% 3.45% 8.58% 6.99% 5.42% Selling & Distn. Exp. - 1.40 0.99 1.68 1.69 1.54 % Of Sales - 1.70% 1.25% 2.66% 1.85% 1.99% Miscellaneous Exp. - 4.50 1.22 4.84 4.22 3.23 % Of Sales - 5.45% 1.53% 7.66% 4.63% 4.18% EBITDA 8.04 1.34 3.07 -26.42 -14.26 0.52 EBITDA Margin 7.44% 1.62% 3.86% -41.80% -15.64% 0.67% Other Income 1.14 4.48 1.11 0.21 0.80 0.74 Interest 1.33 1.03 0.84 2.18 3.10 3.10 Depreciation 1.99 1.60 1.77 7.03 7.35 7.14 PBT 5.84 3.19 1.55 -35.42 -23.90 -8.99 Tax 0.21 0.18 0.03 -7.32 -4.59 10.38 Tax Rate 3.60% 5.64% 1.94% 20.88% 19.21% -115.46% PAT 5.65 -9.97 -19.59 -20.90 -11.29 -19.38 PAT before Minority Interest 5.65 -9.97 -19.59 -31.05 -19.31 -19.38 Minority Interest 0.00 0.00 0.00 10.15 8.02 0.00 PAT Margin 5.23% -12.08% -24.64% -33.07% -12.38% -25.09% PAT Growth 205.41% - - - - EPS 1.92 -3.38 -6.64 -7.08 -3.83 -6.57

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 115.07 69.53 56.78 65.00 64.21 98.42 105.15 114.47 128.28 122.05 Share Capital 29.46 26.25 24.70 24.70 24.70 24.70 16.19 16.19 16.19 16.19 Total Reserves 85.61 43.28 32.08 40.30 39.51 73.71 83.41 98.29 112.09 105.86 Non-Current Liabilities 2.75 1.81 2.62 2.99 3.10 13.65 4.43 6.97 5.24 6.14 Secured Loans 0.13 0.00 0.00 0.00 1.34 11.40 13.86 16.63 10.73 0.34 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 0.88 0.93 1.46 1.65 1.54 1.72 1.48 1.08 1.51 4.34 Current Liabilities 22.84 23.05 33.02 35.46 25.69 45.80 47.39 40.48 24.26 27.92 Trade Payables 13.62 15.44 23.37 25.75 13.39 26.07 27.14 26.65 18.36 15.72 Other Current Liabilities 2.37 1.92 2.67 4.07 4.86 6.56 5.34 4.95 3.60 5.61 Short Term Borrowings 5.90 5.04 5.66 4.91 6.82 12.61 14.47 8.54 2.18 5.28 Short Term Provisions 0.95 0.64 1.32 0.74 0.63 0.56 0.44 0.35 0.13 1.31 Total Liabilities 140.66 94.39 92.42 103.45 93.00 157.87 156.97 161.92 157.78 156.11 Net Block 13.98 13.67 15.01 15.14 14.96 113.02 117.25 124.01 125.31 16.34 Gross Block 25.15 23.27 22.83 21.07 19.64 132.51 131.80 132.11 126.99 23.02 Accumulated Depreciation 11.17 9.60 7.83 5.93 4.68 19.49 14.54 8.10 1.67 6.68 Non Current Assets 106.78 63.34 64.82 66.42 65.13 119.95 125.23 131.23 135.91 126.18 Capital Work in Progress 0.00 0.00 0.00 1.12 0.02 0.11 0.29 0.52 0.00 86.86 Non Current Investment 90.52 46.86 46.85 46.84 46.81 0.02 0.47 0.65 0.65 0.02 Long Term Loans & Adv. 2.19 2.68 2.79 3.10 3.04 6.68 7.04 5.93 9.95 22.96 Other Non Current Assets 0.09 0.13 0.17 0.22 0.31 0.11 0.18 0.12 0.00 0.00 Current Assets 33.88 31.05 27.61 37.04 25.34 37.92 31.74 30.70 21.87 29.94 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 9.20 9.61 11.30 16.59 12.38 13.77 10.05 11.41 7.70 6.69 Sundry Debtors 19.99 16.32 12.75 15.03 9.59 15.56 11.42 10.18 10.69 18.91 Cash & Bank 1.25 0.69 1.08 1.08 0.88 1.53 3.32 1.96 1.84 2.23 Other Current Assets 3.43 1.86 0.40 1.41 2.49 7.06 6.95 7.13 1.65 2.11 Short Term Loans & Adv. 2.21 2.57 2.08 2.93 1.88 0.64 0.54 0.45 0.88 1.89 Net Current Assets 11.03 8.00 -5.42 1.57 -0.34 -7.88 -15.65 -9.79 -2.39 2.02 Total Assets 140.66 94.39 92.43 103.46 90.47 157.87 156.97 161.93 157.78 156.12

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21
Shareholder's Funds 98.10 65.59 73.95 87.49 79.15 Share Capital 29.46 26.25 24.70 24.70 24.70 Total Reserves 68.65 39.34 49.25 62.79 54.45 Non-Current Liabilities 2.75 1.81 2.62 11.36 19.31 Secured Loans 0.13 0.00 0.00 9.29 14.44 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 0.88 0.93 1.46 2.17 1.54 Current Liabilities 22.84 23.05 33.02 48.88 63.61 Trade Payables 13.62 15.44 23.37 28.00 30.95 Other Current Liabilities 2.37 1.92 2.67 8.80 17.89 Short Term Borrowings 5.90 5.04 5.66 11.05 13.64 Short Term Provisions 0.95 0.64 1.32 1.03 1.13 Total Liabilities 123.69 90.45 109.59 194.56 162.07 Net Block 13.98 13.67 15.01 110.01 107.56 Gross Block 25.15 23.27 22.83 142.81 133.42 Accumulated Depreciation 11.17 9.60 7.83 32.79 25.86 Non Current Assets 89.82 59.40 81.99 133.37 112.19 Capital Work in Progress 0.00 0.00 0.00 15.11 0.83 Non Current Investment 73.55 42.91 64.03 0.06 0.02 Long Term Loans & Adv. 2.19 2.68 2.79 7.97 3.48 Other Non Current Assets 0.09 0.13 0.17 0.22 0.31 Current Assets 33.88 31.05 27.61 61.18 47.36 Current Investments 0.00 0.00 0.00 0.00 0.00 Inventories 9.20 9.61 11.30 27.52 23.60 Sundry Debtors 19.99 16.32 12.75 17.66 13.70 Cash & Bank 1.25 0.69 1.08 3.81 1.70 Other Current Assets 3.43 1.86 0.40 1.55 8.35 Short Term Loans & Adv. 2.21 2.57 2.08 10.64 7.70 Net Current Assets 11.03 8.00 -5.42 12.30 -16.25 Total Assets 123.70 90.45 109.60 194.55 159.55

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 2.63 -9.80 0.55 3.12 -0.90 -9.39 -5.04 -6.18 9.56 8.12 PBT 3.23 1.55 -8.18 0.67 -8.44 -13.51 -14.95 -17.53 2.48 10.69 Adjustment 1.41 1.52 2.76 2.43 10.23 11.76 9.24 9.83 3.26 0.67 Changes in Working Capital -2.52 -13.08 6.17 0.29 1.51 -7.62 1.22 2.31 5.55 2.15 Cash after chg. in Working capital 2.12 -10.00 0.74 3.39 3.30 -9.38 -4.48 -5.40 11.29 13.51 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid 0.51 0.20 -0.19 -0.26 -4.20 -0.01 -0.56 -0.78 -1.73 -5.39 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -45.14 0.18 -0.40 1.12 -0.74 -2.33 1.12 -5.14 -16.80 -13.56 Net Fixed Assets -1.88 -0.44 -0.64 -2.53 112.96 -0.53 0.54 -5.64 -17.11 -35.68 Net Investments -43.66 -0.01 -0.01 -0.03 -46.79 0.45 0.18 0.00 -0.63 0.00 Others 0.40 0.63 0.25 3.68 -66.91 -2.25 0.40 0.50 0.94 22.12 Cash from Financing Activity 42.43 9.72 -0.21 -4.22 1.31 9.61 5.78 11.82 7.01 4.32 Net Cash Inflow / Outflow -0.08 0.10 -0.06 0.02 -0.33 -2.10 1.85 0.51 -0.23 -1.12 Opening Cash & Equivalents 0.13 0.02 0.08 0.06 0.40 2.50 0.65 0.14 0.37 1.49 Closing Cash & Equivalent 0.04 0.13 0.02 0.08 0.06 0.40 2.50 0.65 0.14 0.37

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21
Cash From Operating Activity 2.63 -9.80 -14.49 -37.44 4.46 PBT -9.79 -19.57 -38.37 -23.90 -8.99 Adjustment 14.43 22.64 12.61 11.05 10.29 Changes in Working Capital -2.52 -13.08 11.43 -24.33 7.37 Cash after chg. in Working capital 2.12 -10.00 -14.34 -37.18 8.66 Interest Paid 0.00 0.00 0.00 0.00 0.00 Tax Paid 0.51 0.20 -0.15 -0.26 -4.20 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -45.14 0.18 0.49 -24.91 -5.13 Net Fixed Assets -1.88 -0.44 -0.64 -2.53 Net Investments -43.66 -0.01 -0.01 -0.03 Others 0.40 0.63 1.14 -22.35 Cash from Financing Activity 42.43 9.72 11.41 64.07 1.16 Net Cash Inflow / Outflow -0.08 0.10 -2.58 1.72 0.49 Opening Cash & Equivalents 0.13 0.02 2.61 0.88 0.40 Closing Cash & Equivalent 0.04 0.13 0.02 2.61 0.88

Financial Ratios

Standalone /

Consolidated

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 39.06 26.49 22.76 26.06 25.99 39.84 51.31 58.97 66.08 62.87 ROA 2.60% 1.64% -8.36% 0.68% -12.43% -15.48% -9.29% -8.64% 1.06% 7.29% ROE 3.31% 2.42% -13.44% 1.03% -19.17% -24.62% -13.83% -11.38% 1.33% 9.11% ROCE 4.35% 3.50% -11.21% 1.87% -5.24% -7.77% -8.60% -10.64% 2.59% 9.69% Fixed Asset Turnover 3.41 3.45 2.53 3.78 1.02 0.53 0.42 0.44 0.86 3.61 Receivable days 80.26 66.75 91.32 58.39 59.40 70.66 71.64 66.94 83.32 87.15 Inventory Days 41.59 48.02 91.65 68.68 61.77 62.40 71.18 61.28 40.49 32.44 Payable days 98.11 125.11 221.56 144.92 150.71 126.49 149.31 121.22 121.35 94.73 Cash Conversion Cycle 23.75 -10.34 -38.60 -17.85 -29.54 6.57 -6.50 7.00 2.46 24.87 Total Debt/Equity 0.05 0.07 0.10 0.08 0.13 0.27 0.31 0.24 0.11 0.05 Interest Cover 4.14 2.84 -9.67 1.99 -1.60 -3.03 -4.05 -6.29 3.46 14.62

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21
Book Value (Rs.) 33.30 24.99 29.65 35.07 32.04 ROA -9.31% -19.59% -20.41% -10.83% -11.95% ROE -12.18% -28.08% -38.46% -23.18% -24.48% ROCE -10.03% -24.92% -37.83% -18.72% -5.33% Fixed Asset Turnover 3.41 3.45 0.76 0.66 0.58 Receivable days 80.26 66.75 87.83 62.77 64.72 Inventory Days 41.59 48.02 112.11 102.32 111.53 Payable days 98.11 125.11 185.27 171.35 237.48 Cash Conversion Cycle 23.75 -10.34 14.66 -6.26 -61.23 Total Debt/Equity 0.06 0.08 0.08 0.28 0.40 Interest Cover -8.52 -22.16 -16.58 -6.72 -1.90

Top Investors:

quant mutual fund - quant business cycle fund

saumik ketankumar doshi

one up financial consultants pvt ltd

ramesh thakurdas jaisinghani

Annual Reports:

News Update:

Brooks Laboratories - Quarterly Results
13th Aug 2025, 16:49 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback